The purpose of this paper was to determine the effects of anticoagulant type, centrifuge speed, storage, freeze-thaw cycling and interfering substances on the quantification of osteoprotegerin (OPG) in plasma and serum from healthy individuals.
Influence of pre-analytical and analytical factors on osteoprotegerin measurements.
Pérez de Ciriza C, Lawrie A, Varo N
Purpose
Conclusion
OPG levels were higher in EDTA, heparin and citrate anticoagulated plasma than in serum; however, plasma levels were modestly to strongly correlated with those in serum. OPG levels were significantly higher in serum from blood stored for 2 h at 4°C or for 6 h at room temperature or 4°C before centrifugation than in serum from blood centrifuged after 30 min. OPG levels were stable in serum stored for 24 h at room temperature or 48 h at 4°C, but OPG levels were significantly elevated when specimens were stored for 48 h at room temperature after centrifugation rather than immediately assayed. Serum OPG levels increased slightly with each additional freeze-thaw cycle, but the increase was only significant in specimens subjected to 4 cycles compared to 1. Increasing levels of hemoglobin or hemolysate led to negative bias in the measurement of OPG, and triglycerides led to a positive bias in the measurement of OPG. Neither centrifugation speed nor the addition of bilirubin or Receptor activator of nuclear factor kappa-B ligand (RANKL) affected the measurement of OPG.
Studies (2)
Purpose
The purpose of this study was to determine the effects of anticoagulant type and using serum rather than plasma on the quantification of OPG. Plasma and serum specimens were collected from 45 healthy individuals. All specimens were centrifuged at 2500 g for 7 min and then frozen at -20°C before analysis.
Summary of Findings
OPG levels were 29.5%, 19.1% and 24.1% higher in EDTA, heparin and citrate anticoagulated plasma, respectively, than in serum (p<0.0001, all); however, plasma levels were modestly (EDTA and citrate, R=0.684 and R=0.609, respectively) or strongly (heparin R=.757) correlated with those in serum. OPG levels in EDTA plasma were strongly correlated with those in citrated or heparinated plasma (R=0.849 and R=0.888, respectively).
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
GlycoproteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateEDTAHeparinNoneBiospecimen Aliquots and Components Blood and blood products PlasmaSerum
Purpose
The purpose of this study was to determine the effects of centrifuge speed, storage before or after centrifugation, freeze-thaw cycling and interfering substances on the quantification of OPG in serum from healthy individuals. 7 serum specimens were used to investigate the effects of delayed centrifugation, centrifugation speed (200 x g, 400 x g, 1000 x g, 2000 x g, 2500 x g, and 3000 x g) and storage. Unless otherwise specified, all specimens were allowed to clot for 30 min, centrifuged at 2500 g for 7 min and then frozen at -20°C before analysis. To determine the effects of interfering substances, erythrocyte lysates, exogenous bilirubin, cholesterol, RANKL, or triglycerides were added to pooled serum from 20 individuals.
Summary of Findings
OPG levels were significantly higher in serum from blood stored for 2 h at 4°C (p<0.05) or for 6 h at room temperature (p<0.001) or 4°C (p<0.0001) before centrifugation than in serum from blood centrifuged after 30 min. OPG levels were stable in serum stored for 24 h at room temperature or 48 h at 4°C, but OPG levels were significantly elevated when specimens were stored for 48 h at room temperature after centrifugation rather than immediately assayed (p<0.001). Serum OPG levels increased slightly with each additional freeze-thaw cycle, but the increase was only significant in specimens subjected to 4 cycles compared to 1 (36.2% higher, p<0.0001). Increasing levels of hemoglobin or hemolysate led to negative bias in the measurement of OPG and triglycerides led to a positive interference in the measurement of OPG. Neither centrifugation speed, nor the addition of bilirubin or RANKL affected the measurement of OPG.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalPlatforms
GlycoproteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 0-12.4 mmol/L hemoglobin0-8 pg/mL RANKL0.86-6.22 mmol/L triglycerides4.6-10.6 mmol/L cholesterol6.8-251.4 umol/L bilirubinBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedMultiple speeds comparedBiospecimen Aliquots and Components Hemolysis Hemolysate addedNo hemolysate addedStorage Freeze/thaw cycling 1 cycle2 cycles3 cycles4 cyclesStorage Storage duration 2 h24 h30 min48 h6 hStorage Storage temperature 4°CRoom temperature